Nevro Pretax Profit Margin from 2010 to 2025

NVRO Stock  USD 5.85  0.01  0.17%   
Nevro Corp Pretax Profit Margin yearly trend continues to be very stable with very little volatility. Pretax Profit Margin is likely to drop to -0.29. During the period from 2010 to 2025, Nevro Corp Pretax Profit Margin quarterly data regression pattern had range of 1.1021 and standard deviation of  0.42. View All Fundamentals
 
Pretax Profit Margin  
First Reported
2010-12-31
Previous Quarter
(0.28)
Current Value
(0.29)
Quarterly Volatility
0.41746864
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nevro Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nevro Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.8 M, Interest Expense of 28.2 M or Selling General Administrative of 225 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.0 or PTB Ratio of 0.57. Nevro financial statements analysis is a perfect complement when working with Nevro Corp Valuation or Volatility modules.
  
Check out the analysis of Nevro Corp Correlation against competitors.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

Latest Nevro Corp's Pretax Profit Margin Growth Pattern

Below is the plot of the Pretax Profit Margin of Nevro Corp over the last few years. It is Nevro Corp's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nevro Corp's overall financial position and show how it may be relating to other accounts over time.
Pretax Profit Margin10 Years Trend
Slightly volatile
   Pretax Profit Margin   
-0.2600-0.2300-0.34000.0105-0.2800-0.2900100%
       Timeline  

Nevro Pretax Profit Margin Regression Statistics

Arithmetic Mean(0.50)
Coefficient Of Variation(82.92)
Mean Deviation0.38
Median(0.28)
Standard Deviation0.42
Sample Variance0.17
Range1.1021
R-Value0.79
Mean Square Error0.07
R-Squared0.63
Significance0.0003
Slope0.07
Total Sum of Squares2.61

Nevro Pretax Profit Margin History

2025 -0.29
2024 -0.28
2022 0.0105
2021 -0.34
2020 -0.23
2019 -0.26

About Nevro Corp Financial Statements

Nevro Corp investors utilize fundamental indicators, such as Pretax Profit Margin, to predict how Nevro Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.28)(0.29)
When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:
Check out the analysis of Nevro Corp Correlation against competitors.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.06)
Revenue Per Share
11.015
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.1)
Return On Equity
(0.43)
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Trending Assets

CNMD
CONMED
60.35  0.67  1.12 
SGHT
Sight Sciences
2.68  -0.01  -0.37 
GKOS
Glaukos Corp
103.13  -3.78  -3.54 
NPCE
Neuropace
12.72  0.59  4.86 
News Freq…Investor S…100%